- 12 min ago This Winter Season, Keep Your Nail Game Strong With These Superb Trending Colours
- 1 hr ago Aamir Khan's Laal Singh Chaddha Look Is So In Tune With The Fashion Sensibilities Of A Common Man
- 1 hr ago Mickey Mouse 91st Birthday: Lesser Known Facts About Disney's Most Famous Cartoon Character
- 1 hr ago Dysphagia (Swallowing Difficulty): Types, Symptoms, Causes, Risk Factors, Diagnosis And Treatment
- News APSLPRB Paper 1 Answer Key for Assistant Public Prosecutors Written Exam released
- Technology Samsung Camera App Hints At Galaxy S11 Series Optical Specs
- Automobiles Tata Motors Bags Order For 500 Electric Vehicles From Lithium Urban Technologies
- Sports Virat Kohli wins hearts with his sweet gesture for a special fan after victory in Indore Test
- Movies Aamir Khan Was Very 'Sorry' And 'Upset' When Thugs Of Hindostan Flopped At Box Office!
- Travel Gangotri - Truly A Hiker's Paradise
- Finance HDFC Bank Cuts FD Interest Rates By As Much As 0.15%
- Education JEE Main 2020 Sample Question Paper With Solution For Numerical Value Section
Alzheimer's disease is an irreversible, progressive brain disorder that causes the brain cells to degenerate and die, resulting in a decline in thinking, memory, behavioural and social skills.
According to the Alzheimer's Association, more than 4 million people in India have some form of dementia. It is estimated that at least 44 million people are living with dementia.
New treatments are still under way to stop, slow or prevent Alzheimer's disease and some of them have been unsuccessful.
The brain disorder is caused by the accumulation of plaque deposits in the brain, which eventually becomes toxic to brain cells. These plaque deposits are one of the biggest problems that are coming in the way to finding a cure for Alzheimer's disease because it's impossible to clear out the deposits from the brain tissue.
However, in a very recent breakthrough for Alzheimer's disease, United Neuroscience, a biotech company founded by Dr Chang Yi Wang, a prolific bio-inventor, her daughter Mei Mei Hu, and son-in-law, Louis Reese announced the results of Phase II a clinical trial on UB-311, an Alzheimer's vaccine.
This vaccine contains synthetic versions of amino acid chains that stimulate the antibodies to attack Alzheimer's protein in the blood, without causing any side effects. The antibodies were analysed in some patients and there was an almost 100% response rate.
Researchers believe that the vaccine can delay the onset of Alzheimer's disease by five years.
Currently, the company is working on the next clinical trial of the vaccine and its goal is to create innumerable vaccines that will be used to protect people from chronic illnesses.